Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 2171155

[Acyclovir-resistant herpes simplex virus].

P Aukrust
View original source ↗Export metadata ↓

Abstract

Infection with acyclovir-resistant herpes simplex-virus is now a clinical reality in patients with AIDS or who are otherwise immunocompromised. The most common mechanism of resistance is selection of mutants with inability to express thymidine kinase activity. Vidarabine, foscarnet and gancyclovir can be used to treat infections with acyclovir resistant virus. In recent years there have been many reports of drug resistance from the treatment of other virus infections too.

Explore related subjects

AcyclovirDNA-Directed DNA PolymeraseDrug Resistance, MicrobialSimplexvirusThymidine KinaseEnglish AbstractJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Aukrust. 1990-09-10. [Acyclovir-resistant herpes simplex virus].. https://pubmed.ncbi.nlm.nih.gov/2171155/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2005

Neutrophil dysplasia (acquired pseudo-pelger anomaly) caused by ganciclovir.

Two thoracic organ-transplant recipients with persistent cytomegalovirus infection developed morphologic abnormalities in their circulating neutrophils while receiving either ganciclovir or its prodrug valganciclovir. Neither patient was receiving concomitant treatment with mycophenolate mofetil or azathioprine. In both patients, the morphologic abnormalities preceded the development of neutropenia and bone-marrow hypoplasia. The morphologic changes most likely reflected interference of DNA polymerization within bone marrow progenitor cells. The changes resolved completely after the drug was withdrawn.

Acyclovir↗